Are Food Brands Underestimating the Impact of GLP-1s?
Something unprecedented will happen during advertising’s biggest night. Super Bowl 60 will feature what may be the most paradoxical advertiser roster in Big Game history: medications that reduce Americans’ consumption of snacks, alcohol and fast food will share commercial breaks with the very brands that depend on that consumption.
Novo Nordisk, the manufacturer of Wegovy and Ozempic, makes its Super Bowl debut with a star-studded campaign, featuring Kenan Thompson, Danielle Brooks, DJ Khaled and Ana Gasteyer.
Ro will air its first-ever TV spot with Serena Williams.
Hims & Hers, which had a controversial GLP-1 ad last year, returns with escalated rhetoric about “rich people” and healthcare access.
Excerpted from AdWeek
